Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Sodium Sulfate

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 47,663Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Taro's Generic PEG-3350 Receives Approval in US
    Taro's Generic PEG-3350 Receives Approval in US

    28 Jun 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207498

    FDA
    28 Jun 2024
    Share Share
    Bionpharma's Generic Magnesium Sulfate Receives Approval in US
    Bionpharma's Generic Magnesium Sulfate Receives Approval in US

    24 Jun 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204135

    FDA
    24 Jun 2024
    Share Share
    Taro Pharma's Generic Magnesium Sulfate Receives Approval in the U.S
    Taro Pharma's Generic Magnesium Sulfate Receives Approval in the U.S

    19 Mar 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206431

    FDA
    19 Mar 2024
    Share Share
    Alkem Lab's Generic Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Receives Approval in the U.S.
    Alkem Lab's Generic Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Receives Approval in the U.S.

    29 Dec 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213924

    FDA
    29 Dec 2023
    Share Share
    Strides Pharma's Generic Sodium Sulfate, Potassium Sulfate & Magnesium Sulfate Receives Approval in the U.S.
    Strides Pharma's Generic Sodium Sulfate, Potassium Sulfate & Magnesium Sulfate Receives Approval in the U.S.

    22 Nov 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215469

    FDA
    22 Nov 2023
    Share Share
    FDA Confirms Paragraph IV Patent Litigation for Sodium Sulfate, Magnesium Sulfate and Potassium Chloride
    FDA Confirms Paragraph IV Patent Litigation for Sodium Sulfate, Magnesium Sulfate and Potassium Chloride

    25 Apr 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-sodium-sulfate-magnesium-sulfate-and-potassium-chloride-91224.pdf

    FDA
    25 Apr 2023
    Share Share